Destiny Pharma PLC
LSE:DEST
Cash Flow Statement
Cash Flow Statement
Destiny Pharma PLC
| Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
(3)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(6)
|
(7)
|
(8)
|
(7)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Change in Working Capital |
0
|
1
|
1
|
(0)
|
1
|
2
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-50%
|
(5)
-46%
|
(6)
-28%
|
(5)
+23%
|
(4)
+24%
|
(5)
-55%
|
(6)
-14%
|
(5)
+19%
|
(5)
+6%
|
(6)
-23%
|
(5)
+9%
|
(5)
-2%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(5)
|
(4)
|
0
|
0
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(5)
N/A
|
(4)
+20%
|
0
N/A
|
0
-3%
|
5
+8 872%
|
4
-20%
|
(2)
N/A
|
(2)
-1%
|
(0)
+99%
|
0
N/A
|
0
+208%
|
0
+22%
|
0
+169%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
17
|
17
|
0
|
0
|
0
|
0
|
10
|
10
|
0
|
6
|
6
|
7
|
7
|
|
| Cash from Financing Activities |
17
N/A
|
17
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
10
N/A
|
10
+0%
|
0
-100%
|
6
+93 540%
|
6
0%
|
7
+11%
|
7
+0%
|
|
| Change in Cash | ||||||||||||||
| Net Change in Cash |
10
N/A
|
10
-1%
|
(5)
N/A
|
(6)
-28%
|
0
N/A
|
0
+18%
|
2
+359%
|
1
-34%
|
(5)
N/A
|
1
N/A
|
0
-80%
|
1
+471%
|
1
+0%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-50%
|
(5)
-45%
|
(6)
-28%
|
(5)
+23%
|
(4)
+24%
|
(8)
-119%
|
(9)
-10%
|
(5)
+40%
|
(5)
+6%
|
(6)
-23%
|
(5)
+8%
|
(6)
-2%
|
|